Related Experiment Video
Updated: Mar 15, 2026

03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
2.5K
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models
C Pellegrini1, R Colucci2, L Antonioli1
1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Neurogastroenterology and Motility
|September 10, 2016
Summary
Parkinson's disease (PD) may start in the gut, with digestive issues preceding motor symptoms. Research explores how gut inflammation and altered nerve pathways contribute to PD's progression and motor dysfunction.
Area of Science:
- Neuroscience
- Gastroenterology
- Pathology
Background:
- Digestive dysfunction is common in Parkinson's disease (PD), often appearing before motor symptoms.
- The hypothesis that PD originates in the gut is supported by alpha-synuclein aggregates (Lewy bodies) in the enteric nervous system.
- Gut inflammation and oxidative stress may contribute to nigrostriatal neurodegeneration in PD.
Purpose of the Study:
- To critically review knowledge on enteric neuromuscular pathway alterations in PD.
- To examine the role of neuro-immune mechanisms in gastrointestinal dysfunction in PD.
- To discuss findings in both human patients and preclinical PD models.
Main Methods:
- Literature review and critical appraisal of existing research.
- Analysis of studies on enteric nervous system function in PD.
- Examination of evidence linking gut inflammation to PD pathophysiology.
Main Results:
- Alterations in enteric neurotransmission are implicated in PD-related intestinal motility disturbances.
- Neuro-immune interactions play a significant role in aberrant gut activity in PD.
- Preclinical models and human studies show consistent patterns of gastrointestinal involvement.
Conclusions:
- The gut is a key area for understanding PD initiation and progression.
- Enteric neuromuscular and neuro-immune pathways are critical targets for PD research.
- Further investigation into gut-brain axis in PD is warranted.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K

